Evidence-Based Management of Advanced Gastric Cancer: Current and Emerging Targeted Therapies

 

 

Release Date: August 14, 2014

Last Reviewed: July 11, 2014    

Expiration Date: August 14, 2015

 

This activity is provided by Global Education Group. 

Paradigm Medical Communications, LLC is the educational partner.

 

Associate Professor of Medicine

Director, Gastrointestinal Oncology

Weill Cornell Medical College

Associate Attending Physician

Director, Research

Center of Advanced Digestive Care

New York–Presbyterian Hospital

New York, NY

 

Assistant Professor of Medicine

Harvard Medical School

Director, Center for Esophageal and Gastric Cancer

Dana–Farber Cancer Institute

Boston, MA

 

This educational initiative is designed to meet the needs of medical oncologists, surgical oncologists, interventional radiologists, gastroenterologists/endoscopy specialists, colon and rectal surgeons, general surgeons, pathologists, oncology nurses, nurse practitioners, physician assistants, and other healthcare professionalsinvolved in the management of advanced gastric cancer.

 

Gastric cancer is the 2nd leading cause of cancer mortality and the 4th most common malignancy worldwide. An estimated 21,600 new cases of gastric cancer will be diagnosed in the US in 2013, and more than 10,000 people will die of the disease. Although treatment of resectable gastric cancer has improved over the last 2 decades, historically, little progress has been made in advanced gastric cancer. That is beginning to change with the FDA approval of a targeted second-line treatment for metastatic gastric cancer in April 2014, and the ongoing investigation of other promising agents targeting aberrant signaling pathways. These new treatments have the potential to substantially improve patient outcomes. However, with each new treatment, clinicians must stay abreast of the underlying mechanisms, current data, and treatment-emergent adverse events to provide their patients with optimal care. The amount of information surrounding emerging treatments for gastric cancer can be daunting; this monograph will provide clinicians with a much-needed, concise overview of the available data.

 

Upon proper completion of this activity, participants should be better able to:

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1 hour of Category 1 credit for completing this program.

 

Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This educational activity for 1 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

 

Global Education Group is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 1101021.

 

This program has been approved for 1.0 contact hours of continuing education (which includes .50 hours of pharmacology).

 

This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standard.

 

This activity is supported by an independent educational grant from Lilly, USA LLC.

 

To receive a certificate of participation, participants should:

There is no fee required for participation in this activity.

 

This certified CME activity includes HTML5 video interspersed throughout. When you encounter a video highlight, click the ‘play’ button in order to begin viewing the video highlight.

 

For Desktops (Windows/Mac)

Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher

 

For Tablets (iPad/Android/Surface)

iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher

 

In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.

 

 

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

 

 

Paradigm Medical Communications, LLC staff members have no financial conflicts to disclose.

 

Independent peer reviewer has no financial conflicts to disclose.

 

Paradigm Medical Communications, LLC and Global Education Group have implemented a system to resolve conflicts of interest for each CME activity to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.

 

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.

 

This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC or Global Education Group. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

 

Signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.

 

 

The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC or Global Education Group. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm or Global. Paradigm and Global accept no liability for the content referenced in this activity.

 

Paradigm and Global arecommitted to protecting the privacy of those who participate in the activities (herein referred to as "website") located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

 

This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

 

The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm and Global to continuously improve the learning experience.

 

Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.

 

If you have any questions or comments, please emailus at contactus@paradigmmc.com.

 

© 2014 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.